56TWENTYFOURSEVENBIOPHARMA Issue 3 / October 2025 SUNRESIN a notable advancement in the field of solid-phase peptide synthesis, particularly for C-terminal acid peptides. The findings detail a significant bridging of the gaps between established resins like Wang and CTC, demonstrating through extensive empirical research that MBH Br resin is fast becoming a preferred choice due to its adaptability, efficiency, and lesser associated side effects. We have not only expanded the toolbox available to chemists but have also laid the groundwork for future research directions that could further enhance synthesis outcomes in peptide chemistry. The study highlights the potential for MBH Br resin to facilitate more reliable and efficient peptide syntheses across various applications within the pharmaceutical and biotechnological arenas. At Sunresin, we specialize in high-quality resins for solid-phase peptide synthesis. Our innovative solutions help researchers and manufacturers achieve efficient and reliable synthesis, improving both productivity and purity. The Sunresin team is ready to support you in developing your process with our new MBH Br resin. We can provide samples, technical guidance, and practical tips to help you achieve optimal results. Contact us at info.lifescience@sunresin.com Reference Hassan Gamal, Mani Kaushal, Ashish Kumar, Sikabwe Noki, Cheng Zhang, Chaoyang Wang, Xiaokang Kou, Alessandra Basso, Simona Serban, Beatriz G. de la Torre, and Fernando Albericio, “4-Methylbenzhydryl Bromine Resin: Bridging the Gap between 2-Chlorotrityl Chloride and Wang-Type Resins for the Solid-Phase Synthesis of C-Terminal Acid Peptides”, Chemistry-Methods 2025, 0, e202500092. https:// doi.org/10.1002/cmtd.202500092 ALESSANDRA BASSO Global Sales & Marketing Director - Life Science Sunresin SIMONA SERBAN Global Life Science Applications Director Sunresin
RkJQdWJsaXNoZXIy MjY2OTA4MA==